213 related articles for article (PubMed ID: 18418580)
1. Human CYP2E1 mediates the formation of glycidamide from acrylamide.
Settels E; Bernauer U; Palavinskas R; Klaffke HS; Gundert-Remy U; Appel KE
Arch Toxicol; 2008 Oct; 82(10):717-27. PubMed ID: 18418580
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors.
Kurebayashi H; Ohno Y
Arch Toxicol; 2006 Dec; 80(12):820-8. PubMed ID: 16699760
[TBL] [Abstract][Full Text] [Related]
3. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts.
Ghanayem BI; McDaniel LP; Churchwell MI; Twaddle NC; Snyder R; Fennell TR; Doerge DR
Toxicol Sci; 2005 Dec; 88(2):311-8. PubMed ID: 16141435
[TBL] [Abstract][Full Text] [Related]
4. The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitro.
Kraus D; Rokitta D; Fuhr U; Tomalik-Scharte D
Toxicol Mech Methods; 2013 Jun; 23(5):346-51. PubMed ID: 23256458
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of acrylamide in vitro: Acrylamide is not metabolically activated in standard in vitro systems.
Koyama N; Yasui M; Oda Y; Suzuki S; Satoh T; Suzuki T; Matsuda T; Masuda S; Kinae N; Honma M
Environ Mol Mutagen; 2011 Jan; 52(1):11-9. PubMed ID: 20209648
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of Acrylamide: Interindividual and Interspecies Differences as Well as the Application as Biomarkers.
Li D; Wang P; Liu Y; Hu X; Chen F
Curr Drug Metab; 2016; 17(4):317-26. PubMed ID: 26467066
[TBL] [Abstract][Full Text] [Related]
7. DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells.
Puppel N; Tjaden Z; Fueller F; Marko D
Mutat Res; 2005 Feb; 580(1-2):71-80. PubMed ID: 15668109
[TBL] [Abstract][Full Text] [Related]
8. The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans.
Pellè L; Carlsson H; Cipollini M; Bonotti A; Foddis R; Cristaudo A; Romei C; Elisei R; Gemignani F; Törnqvist M; Landi S
Arch Toxicol; 2018 Jun; 92(6):2137-2140. PubMed ID: 29748789
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species.
Court MH; Von Moltke LL; Shader RI; Greenblatt DJ
Biopharm Drug Dispos; 1997 Apr; 18(3):213-26. PubMed ID: 9113344
[TBL] [Abstract][Full Text] [Related]
10. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
Wall KL; Crivello J
Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
[TBL] [Abstract][Full Text] [Related]
11. The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Biol Interact; 1996 Dec; 102(3):169-82. PubMed ID: 9021169
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
Ligocka D; Lison D; Haufroid V
Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics of acrylamide in primary rat hepatocytes: coupling to glutathione is faster than conversion to glycidamide.
Watzek N; Scherbl D; Schug M; Hengstler JG; Baum M; Habermeyer M; Richling E; Eisenbrand G
Arch Toxicol; 2013 Aug; 87(8):1545-56. PubMed ID: 23568512
[TBL] [Abstract][Full Text] [Related]
14. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
[TBL] [Abstract][Full Text] [Related]
15. The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide.
Taubert D; Glöckner R; Müller D; Schömig E
Toxicol Lett; 2006 Jun; 164(1):1-5. PubMed ID: 16337756
[TBL] [Abstract][Full Text] [Related]
16. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide.
Tareke E; Twaddle NC; McDaniel LP; Churchwell MI; Young JF; Doerge DR
Toxicol Appl Pharmacol; 2006 Nov; 217(1):63-75. PubMed ID: 17007897
[TBL] [Abstract][Full Text] [Related]
17. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect.
Ghanayem BI; Witt KL; Kissling GE; Tice RR; Recio L
Mutat Res; 2005 Oct; 578(1-2):284-97. PubMed ID: 15982677
[TBL] [Abstract][Full Text] [Related]
18. Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression.
Mapoles J; Berthou F; Alexander A; Simon F; Ménez JF
Eur J Biochem; 1993 Jun; 214(3):735-45. PubMed ID: 8391436
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
20. The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide.
Huang YF; Chiang SY; Liou SH; Chen ML; Chen MF; Uang SN; Wu KY
Toxicol Lett; 2012 Nov; 215(2):92-9. PubMed ID: 23069881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
